AAP
26
2
CTAS
49
6
EXPE
69
5
AEE
84
2
EQR
47
2
AMGN
47
16
GS
62
14
EMR
60
4
DLTR
43
3
BAC
65
2
GE
65
3
ADP
69
3
AES
57
3
FRT
50
4
CHRW
65
5
BEN
36
2
KO
68
16
IBM
57
2
DE
62
2
ADM
39
3
AAP
26
2
CTAS
49
6
EXPE
69
5
AEE
84
2
EQR
47
2
AMGN
47
16
GS
62
14
EMR
60
4
DLTR
43
3
BAC
65
2
GE
65
3
ADP
69
3
AES
57
3
FRT
50
4
CHRW
65
5
BEN
36
2
KO
68
16
IBM
57
2
DE
62
2
ADM
39
3
Financhill
Back

Rocket Companies 10K Form

Sell
49

RKT
Rocket Companies

Last Price:
$15.73
Seasonality Move:
-4.62%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RKT News And Ratings

See the #1 stock for the next 7 days that we like better than RKT

RKT Financial Statistics

Sales & Book Value

Annual Sales: $4.9B
Cash Flow: $1.7B
Price / Cash Flow: 0
Annual Sales: $4.81
Price / Book: 3.12

Profitability

EPS (TTM): 0.16000
Net Income (TTM): $29.4M
Gross Margin: $1.9B
Return on Equity: 0.34%
Return on Assets: 0.13%

Rocket Companies Earnings Forecast

Key Rocket Companies Financial Ratios

  • The Gross Profit Margin over the past 10 years for RKT is 19.54%.
  • The Selling, General & Administrative Expenses for RKT have been equal to 80.66% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 19.87% of Operating Income.
  • The Net Earning history of RKT is 0.60% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 10 years.

Rocket Companies Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Financial Services
Sector: Financials
Current Symbol: RKT
Website: ir.rocketcompanies.com

Debt

Debt-to-Equity Ratio: 7.14
Current Ratio: 0.55
Quick Ratio: 0.21

Price-to-Earnings

Trailing P/E Ratio: 70.81
Forward P/E Ratio: 18.99

RKT Technical Analysis vs Fundamental Analysis

Sell
49
Rocket Companies (RKT) is a Sell

Is Rocket Companies a Buy or a Sell?

  • Rocket Companies stock is rated a Sell
    The current Rocket Companies [RKT] share price is $15.71. The Score for RKT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.